Tempest Therapeutics, Inc. Share Price
TPSTTempest Therapeutics, Inc. Stock Performance
Open $1.57 | Prev. Close $1.59 | Circuit Range N/A |
Day Range $1.56 - $1.60 | Year Range $1.52 - $12.06 | Volume 1,607 |
Average Traded $1.58 |
Tempest Therapeutics, Inc. Share Price Chart
About Tempest Therapeutics, Inc.
Tempest Therapeutics, Inc., a clinical-stage biotechnology company, develops small molecule therapeutics to treat cancer. Its clinical-stage lead product candidates include Amezalpat, an oral small molecule selective antagonist of peroxisome proliferator-activated receptor alpha for the treatment of first-line unresectable or metastatic hepatocellular carcinoma; and TPST-1495, a small-molecule dual antagonist of the EP2 and EP4 receptors of prostaglandin E2 for treating various cancers. The company has a collaboration agreement with F. Hoffmann-La Roche Ltd. for the development of Amezalpat into a global first-line randomized study. Tempest Therapeutics, Inc. is headquartered in Brisbane, California. Tempest Therapeutics, Inc. operates as a subsidiary of Inception Sciences, Inc.
Tempest Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
08-Apr-26 | $1.57 | $1.56 | +0.00% |
08-Apr-26 | $1.57 | $1.56 | +0.65% |
07-Apr-26 | $1.54 | $1.55 | -2.52% |
06-Apr-26 | $1.60 | $1.59 | -1.24% |
01-Apr-26 | $1.65 | $1.61 | -0.62% |
31-Mar-26 | $1.53 | $1.62 | +6.58% |
30-Mar-26 | $1.65 | $1.52 | -11.88% |
FAQs on Tempest Therapeutics, Inc. Share Price
Can I buy Tempest Therapeutics, Inc. shares in India?
What is the share price of Tempest Therapeutics, Inc.?
What is the 5 year returns of Tempest Therapeutics, Inc.?
What are the high & low stock price of Tempest Therapeutics, Inc. today?
What is the 52-week high and low of Tempest Therapeutics, Inc. stock?